<DOC>
	<DOCNO>NCT02973217</DOCNO>
	<brief_summary>Thermotherapy technology aim destroy tissue , example tumor tissue . Immunostimulating Interstitial Laser Thermotherapy ( imILT ) specific form thermotherapy , , addition destroy tumor tissue , optimize cause tumor specific immunologic response . In laboratory animal imILT method also show induce call abscopal effect . This mean one tumor treat imILT , untreated , tumor also decrease size . The purpose trial evaluate efficiency come local tumor destruction imILT treatment method patient diagnose pancreatic cancer . The purpose also investigate functionality safety well understanding subsequent immunological effect . This trial prospective , open non-randomized . Five patient diagnose pancreatic cancer treat trial , estimate carried time period 36 month .</brief_summary>
	<brief_title>Immunostimulating Interstitial Laser Thermotherapy Pancreatic Cancer</brief_title>
	<detailed_description />
	<criteria>Cytohistological diagnosis ductal pancreatic adenocarcinoma . Stage III disease ( see ) . The patient candidate continue chemotherapy ( chemo ) radiotherapy due lack demonstrable efficiency side effect drug . Age 18 80 year . Anticipated compliance treatment followup . Double informed consent imILT possible surgery radical intent ( event preoperative overstaging ) . At least part tumor treat imILT without damage surround vital structure . Have ECOG performance status &lt; 1 ( l'Eastern Cooperative Oncology Group ) Not candidate laparotomy . Becoming resectable neoadjuvant chemotherapy . Other simultaneous treatment neoplasm . Simultaneous malignancy except basal cell carcinoma . HIV positive . Active autoimmune disease . Systemic corticosteroid medication . Pregnancy nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hyperthermia , Induced</keyword>
	<keyword>Laser Coagulation</keyword>
	<keyword>Laser Therapy</keyword>
</DOC>